EchoGo® Heart Failure vs FFRct
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, EchoGo® Heart Failure, is designed to detect Heart Failure with preserved Ejection Fraction (HFpEF) through the analysis of routine echocardiograms. In contrast, Tool B, FFRct, focuses on diagnosing coronary artery disease (CAD) by creating personalized 3D models from CCTA scans to assess blood flow. While both are AI-powered cardiology tools that analyze medical imaging, they target different cardiac conditions and utilize distinct imaging modalities, making them adjacent rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is an AI platform designed to detect Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing routine echocardiograms. HeartFlow FFRct Analysis, conversely, is a non-invasive AI-powered diagnostic tool that aids in diagnosing coronary artery disease (CAD) by assessing blood flow in coronary arteries from CCTA scans.
EchoGou00ae Heart Failure analyzes routine echocardiogram video clips to provide insights. HeartFlow FFRct Analysis utilizes data from CCTA (Coronary Computed Tomography Angiography) scans to create personalized 3D models of coronary arteries.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis. HeartFlow FFRct Analysis has a CMS payment rate of $1,017 for 2025, with commercial payer rates varying.
EchoGou00ae Heart Failure delivers insights within 20 minutes after analyzing routine echo video clips. The provided information for HeartFlow FFRct Analysis does not specify a turnaround time, but it involves cloud-based processing of CCTA data.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection, trained on over 10 years of outcome data. HeartFlow FFRct Analysis is an FDA-cleared diagnostic tool, and studies have shown its diagnostic accuracy for hemodynamically significant coronary stenosis with per-vessel sensitivity of 83.5% and specificity of 85.8%.
EchoGou00ae Heart Failure offers seamless integration with existing workflows and IT stacks, utilizing a DICOM workflow for report delivery to PACS. HeartFlow FFRct Analysis is cloud-based, deploying via the HeartFlow Network, AWS Cloud, or Virtual Private Cloud, and uses a local Virtual Appliance for data transfer.